Trine Hørmann Thomsen

Dr. Trine Hørmann Thomsen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Parkinson's Disease
Verified
Journal Article
Open access
TTTrine Hørmann Thomsen
Trine Hørmann Thomsen
SSSara Lungby Skovbølling
Sara Lungby Skovbølling
MBMaria Brønden
Maria Brønden
JFJakob Frederiksen
Jakob Frederiksen
MLMaja Hedegaard Lauritzen
Maja Hedegaard Lauritzen
BBBo Biering-Sørensen
Bo Biering-Sørensen
Empowerment and implementation of self‐management strategies are vital components in the future care of chronic, neurological patient groups, including people with Parkinson’s disease (PD). This study aimed to evaluate the feasibility and effectiveness of an 8‐week self‐management intervention designed for people with PD (PwP) with follow‐up assessments at 3 and 6 months postintervention. The program focused on developing self‐management skills, coping strategies, disease education, mindfulness, exercise routines, and individual goal‐setting tools. Objective measurements using Parkinson’s KinetiGraph™ (PKG) were employed to monitor motor symptoms, immobility levels, and burden of nonmotor symptoms (self‐reported in the PKG portal). Participants, serving as their own controls, were recruited from movement disorder clinics, private neurologists, and a specialized rehabilitation center. Primary endpoints were change in Health Education Impact Questionnaire (HeiQ) and Health Literacy Questionnaire (HLQ‐14) scores, assessed at baseline and at 3‐ and 6‐month follow‐up. Secondary endpoints included changes in quality of life, self‐efficacy, motor symptoms (PKG data), nonmotor symptoms, contacts to the clinics 6 months before and after the intervention, and time spent with immobility. Eighty PwP completed the program, and 59 caregivers attended the educational sessions. Statistically significant changes were found between baseline and follow‐up in the motor symptom burden, self‐efficacy, and reduced clinical contacts. Although no statistical changes were observed in health literacy, quality of life, and nonmotor symptoms, sustained positive trends were observed. The findings suggest that the program may enhance empowerment and self‐management strategies in PwP, particularly in self‐efficacy level, managing motor symptoms, and less need of contact to the clinics.

15 February 2024 in BMJ Open Quality
Verified
Journal Article
Open access
PDF file
TTTrine Hørmann Thomsen
Trine Hørmann Thomsen
LOLouise Olsen
Louise Olsen
MJMahsa Javidi
Mahsa Javidi
NKNikolaj Folke La Cour Karottki
Nikolaj Folke La Cour Karottki
BBBo Biering-Sørensen
Bo Biering-Sørensen
Background Within Parkinson’s disease (PD) management, a pivotal juncture often arises when individuals with PD (PwP) necessitate advanced therapies to stabilise symptom fluctuations and reduce off-periods, which are intrinsic to living with PD. One such intervention is the infusion of duodenal levodopa–entacapone–carbidopa intestinal gel (LECIG), which confers a more dependable levodopa plasma concentration compared with conventional oral therapy. It involves the insertion of a percutaneous endoscopic gastrojejunostomy (PEG-J) tube, facilitating direct access to the stomach and jejunum. Then, a slender tube extends into the small intestine, facilitating the continuous delivery of LECIG via a portable pump. The PEG-J incorporates an extension tube that permits patients with PD to connect the medication pump. Objective The objective of this study was to assess and compare two types of extension tubes a standard; a standard tube and the ENFit extension tube. Method Employing a prospective, crossover design at a single centre in Denmark. Each participant evaluated both extension tubes for 14 days. The primary outcome measure was patient-reported evaluation measures through a nine-item questionnaire using a 5-point Likert scale and 10th open-ended qualitative question. Results Of the 12 recruited PwP, 10 successfully completed both testing periods and submitted self-reported questionnaires. The participants, with an average age of 70.3 years, comprised three men and seven women. Among them, five had a spouse or cohabitant, while five lived independently (with one residing in a nursing home). The average duration of PD diagnosis was 16.4 years, with an average of 2.6 years since the implantation of the medication pump. The ENFit tube outperformed the standard tube across all nine evaluation criteria, particularly excelling in terms of usability (items 4–6), safety (item 2) and overall product preference (item 9).

8 April 2024 in Parkinson's Disease
Verified
Journal Article
Open access
PDF file
TTTrine Hørmann Thomsen
Trine Hørmann Thomsen
NNNick Schou Nielsen
Nick Schou Nielsen
AIAsher Lou Isenberg
Asher Lou Isenberg
MMMichael Hougaard Møller
Michael Hougaard Møller
JCJesper Bøje Clausen
Jesper Bøje Clausen
BBBo Biering-Sørensen
Bo Biering-Sørensen
Background. Testing and titration of the right levodopa equivalent dose are usually performed during a hospital admission. However, optimal dose titration in people with Parkinsons disease (PwPs) may depend on home environment, emotional stress, and physical activity of everyday life. Objective. Firstly, to evaluate the feasibility and safety of a home-based LCIG titration program and patients/caregivers satisfaction. Secondly, to identify barriers and facilitators for home-based titration. Method. This study assesses the feasibility and safety of home-based titration of levodopa duodenal infusions with the use of self-reported evaluation questionnaires with open-ended questions included, registration of total time used, and number of contacts/visits. A telemedicine solution was used to remotely monitor the patients, adjust treatment, and provide support and guidance to patients and caregivers. Results. Ten of 12 PwPs (5 females and 7 males) completed the total titration program. Eight of the 12 PwPs were dependent on help. These 8 PwPs also had a high burden of nonmotor symptoms (NMS). Cognitive impairments varied in severity (range 1630). Time spent with home visits was on average 93.4minutes (ranging from 35 to 180minutes), and the length of the total titration (LCIG initiation to termination of titration) was on average 3.4days with 25 (mean 3.2) contacts/visits with PD team members. The average score on the satisfaction evaluation questionnaires was lower in the caregiver group (mean 31.8) than the PwP outcome (mean 36.2). Conclusions. Telehealth-assisted home-based titration programs are feasible due to the length of the titration period, number of contacts, and time spent in PwPs private homes, are rated satisfactory and safe by PwPs and caregivers, and may be a substitute for in-hospital treatment. Clinical recommendations including facilitators and barriers from a patient/caregiver perspective are displayed. This trial is registered with NCT4196647.

31 October 2022 in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
Verified
Journal Article
Open access
TTTrine Hørmann Thomsen
Trine Hørmann Thomsen
LJLene Bastrup Jørgensen
Lene Bastrup Jørgensen
TKTroels Wesenberg Kjær
Troels Wesenberg Kjær
AHAnita Haahr
Anita Haahr
AVAsmus Vogel
Asmus Vogel
KWKristian Winge
Kristian Winge
People with Parkinson’s disease (PwP) experience a variety of symptoms and fluctuations in these, which they have to cope with every day. In tailoring a person-centered treatment to PwP there is a lack of knowledge about the association between pre-dominant coping behaviors and clinical markers among PwP. To describe and compare specific clinical markers between 6 suggested coping behaviors. Thirty-four PwP, who previously had been classified into 6 different pre-dominant coping behaviors, were included in this mixed methods study. Six primary variables were included in the descriptive analysis; motor function (UPDRS-III), non-motor symptoms score (NMS-Quest), change in bradykinesia score, apathy score (LARS), personality traits (NEO-FFI), and cognitive status (evaluated by a neuropsychologist). The merged results of this mixed methods study indicate that clinical markers as apathy, burden of non-motor symptoms, cognitive impairments and personality traits, have the potential to impact the coping behavior in PwP. In a clinical setting the markers; NMS-burden, degree of apathy, cognition, and personality traits may indicate specific coping behavior. Three of the six suggested typologies of coping behaviors differed from the other groups when comparing descriptive data. In order to improve patient care and guide the development of person-centered therapies, each PwP should be approached based on those typologies.

18 March 2026 in medRxiv
Verified
Preprint
Open access
PDF file
JVJúlia Rey Vilches
Júlia Rey Vilches
CGChiara Gorlini
Chiara Gorlini
STSilvia Tolu
Silvia Tolu
TTTrine Hørmann Thomsen
Trine Hørmann Thomsen
BBBo Biering-Sørensen
Bo Biering-Sørensen
Sadasivan PuthusserypadySadasivan Puthusserypady
Sadasivan Puthusserypady
Early-stage Parkinson’s disease (PD) presents motor impairments that are difficult to detect clinically. Surface EMG (sEMG) offers an objective alternative, yet many studies rely on non-standardized tasks and provide limited task- and symptom-specific interpretability. This study analyzes sEMG recorded during standardized MDS-UPDRS-III upper-limb tasks—pronation–supination and postural tremor—performed by individuals with early-stage PD (Hoehn and Yahr 1–3, n=31) and healthy controls (n=30). Time-, frequency-, and nonlinear features were extracted and evaluated using a two-stage framework combining filter-based ranking and wrapper-based methods to support feature selection across multiple classifiers and interpretability. Pronation–supination showed the strongest single-task discrimination (balanced accuracy 0.79±0.181), driven by rhythm and nonlinear features reflecting impaired rhythmicity, reduced neuromuscular complexity, and unstable muscle deactivation, consistent with bradykinesia and rigidity. The postural tremor task highlighted tremor-specific spectral changes and reduced signal complexity during sustained posture (balanced accuracy 0.75±0.18), capturing low-frequency oscillations typical of PD tremor. Combining both tasks further improved classification without increasing feature dimensionality (balanced accuracy 0.83±0.186), indicating complementary diagnostic information. Filter-guided selection enhanced robustness and consistency across models. Beyond classification, this study highlights the value of interpretable, task-aligned motor quantification, showing that standardized clinical movements combined with targeted sEMG analysis can support explainable assessment of early-stage PD motor symptoms.

Verified
Journal Article
Open access
PDF file
MHMarcus Dalsgaard Hansen
Marcus Dalsgaard Hansen
Filip BergquistFilip Bergquist
Filip Bergquist
TTTrine Hørmann Thomsen
Trine Hørmann Thomsen
Background: Parkinson’s Disease is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. Effective management is critical to improving patient outcomes but is limited by the subjectivity of retrospective assessments of motor symptom burden. The objectives were to describe the weekly variability of objective bradykinesia score (BKS) derived from a wrist-worn device and assess the correlation between BKS variability and the Quality of Life (QoL) of People with Parkinson’s disease (PwP). Method: This observational, longitudinal study is part of the overall self-management project, Empower-PD. The study population consists of 80 PwP. Participants wore a wrist-worn accelerometer watch that measures movement during daily activities to evaluate the degree of bradykinesia as the bradykinesia score (BKS). Weekly median BKSs were collected over a 10-week period. Quality of life was assessed with the PDQ-39 questionnaire at baseline and after 10 weeks. Descriptive statistics assessed BKS variation and distribution. Linear and logistic regression models examined correlations between variability in BKS and QoL. Results: Results showed that 95% of BKS weekly changes were in a range between −4.3 and +4.4 points, with a central tendency near zero. The distribution of BKSs over time indicated that most participants exhibited stable BKSs. No significant correlation was found between BKS changes and QoL at 10 weeks. Conclusions: This study successfully described weekly BKS variations over ten weeks in PwP using objective measurements. The results showed that 95% of all value changes in BKS ranged from −4.3 to 4.4, values which may serve as preliminary distribution-based reference bounds that could inform the design of future studies examining clinically significant changes in BKS.